Ocugen (OCGN) Research Hub

Ocugen (OCGN) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 0.7084 USD (-4.23%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -5.54, market cap 0.44B. This hub links to the full technical, earnings and options research available for OCGN.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, US
Last close0.7084 USD (-4.23%)
52-week range0.7016 USD – 1.69 USD
Trend regimeRange
14-day RSI8.7 (Oversold)
Trailing P/E-5.54
Market cap0.44B
Dividend yield0.00%
Next earnings2026-07-30

Available research for OCGN

Earnings

OCGN earnings date and last-quarter result: next report 2026-07-30, last quarter in line, P/E -5.54. Updated 2026-07-23.

Options: Covered Call

Covered Call on OCGN: how it works, illustrative setup around the real 0.7084 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on OCGN: how it works, illustrative setup around the real 0.7084 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on OCGN: how it works, illustrative setup around the real 0.7084 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

OCGN technical analysis: range, last 0.7084 USD, RSI 8.7, 52w range 0.7016 USD–1.69 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is OCGN in?

Ocugen (OCGN) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.

Is OCGN in an uptrend or downtrend?

As of 2026-10-26, OCGN is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is OCGN's trailing P/E ratio?

OCGN's trailing P/E is -5.54, with a market cap of 0.44B. See the earnings research page for full valuation detail.

When does OCGN next report earnings?

OCGN is next scheduled to report earnings on 2026-07-30.